Document Detail


Skeletal muscle protein tyrosine phosphatase activity and tyrosine phosphatase 1B protein content are associated with insulin action and resistance.
MedLine Citation:
PMID:  8132755     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Particulate and cytosolic protein tyrosine phosphatase (PTPase) activity was measured in skeletal muscle from 15 insulin-sensitive subjects and 5 insulin-resistant nondiabetic subjects, as well as 18 subjects with non-insulin-dependent diabetes mellitus (NIDDM). Approximately 90% of total PTPase activity resided in the particulate fraction. In comparison with lean nondiabetic subjects, particulate PTPase activity was reduced 21% (P < 0.05) and 22% (P < 0.005) in obese nondiabetic and NIDDM subjects, respectively. PTPase1B protein levels were likewise decreased by 38% in NIDDM subjects (P < 0.05). During hyperinsulinemic glucose clamps, glucose disposal rates (GDR) increased approximately sixfold in lean control and twofold in NIDDM subjects, while particulate PTPase activity did not change. However, a strong positive correlation (r = 0.64, P < 0.001) existed between particulate PTPase activity and insulin-stimulated GDR. In five obese NIDDM subjects, weight loss of approximately 10% body wt resulted in a significant and corresponding increase in both particulate PTPase activity and insulin-stimulated GDR. These findings indicate that skeletal muscle particulate PTPase activity and PTPase1B protein content reflect in vivo insulin sensitivity and are reduced in insulin resistant states. We conclude that skeletal muscle PTPase activity is involved in the chronic, but not acute regulation of insulin action, and that the decreased enzyme activity may have a role in the insulin resistance of obesity and NIDDM.
Authors:
J Kusari; K A Kenner; K I Suh; D E Hill; R R Henry
Related Documents :
571925 - Gluconeogenic response during glucose infusions in patients following skeletal trauma o...
21051155 - The combination of bortezomib and resveratrol may prevent muscle wasting in diabetes.
15824195 - Mechanisms of insulin resistance in humans and possible links with inflammation.
2393555 - Changes in muscle glucose metabolism in type 1 diabetes.
20503255 - The a1c and abcd of glycaemia management in type 2 diabetes: a physician's personalized...
8772865 - Prevalence of diabetes in the young in south india.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  The Journal of clinical investigation     Volume:  93     ISSN:  0021-9738     ISO Abbreviation:  J. Clin. Invest.     Publication Date:  1994 Mar 
Date Detail:
Created Date:  1994-04-21     Completed Date:  1994-04-21     Revised Date:  2009-11-18    
Medline Journal Info:
Nlm Unique ID:  7802877     Medline TA:  J Clin Invest     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1156-62     Citation Subset:  AIM; IM    
Affiliation:
Department of Medicine, University of California, San Diego, La Jolla 92093.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Diabetes Mellitus, Type 2 / enzymology
Glucose / metabolism
Humans
Insulin / pharmacology*
Insulin Resistance*
Middle Aged
Muscles / enzymology*
Protein Tyrosine Phosphatases / analysis,  metabolism*
Weight Loss
Grant Support
ID/Acronym/Agency:
DK 38949/DK/NIDDK NIH HHS; MO1 RR00827/RR/NCRR NIH HHS
Chemical
Reg. No./Substance:
11061-68-0/Insulin; 50-99-7/Glucose; EC 3.1.3.48/Protein Tyrosine Phosphatases
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Alterations of human placental epidermal growth factor receptor in intrauterine growth retardation.
Next Document:  Metabolic clearance of recombinant human growth hormone in health and chronic renal failure.